Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti-Epidermal Growth Factor Receptor Antibody Therapies
Cancer Research - United States
doi 10.1158/0008-5472.can-06-4158
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2007
Authors
Publisher
American Association for Cancer Research (AACR)